Roche Abandons A Drug To Raise ‘Good’ Cholesterol

More than six years after Pfizer famously abandoned a drug that was designed to raise HDL, or good, cholesterol, Roche is now making the same move. The drugmaker this morning released a brief statemen…
Read the full story: Pharmalot